Mineralocorticoid receptor antagonism improves diastolic dysfunction in chronic kidney disease in mice

Receptor Antagonism ◽

Faculty Opinions recommendation of Reduction of cardiovascular risk in chronic kidney disease by mineralocorticoid receptor antagonism.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725835891.793510469 ◽

2015 ◽

Author(s):

Luis Ruilope ◽

Enrique Morales

Keyword(s):

Chronic Kidney Disease ◽

Cardiovascular Risk ◽

Kidney Disease ◽

Receptor Antagonism ◽

Reduction of cardiovascular risk in chronic kidney disease by mineralocorticoid receptor antagonism

The Lancet Diabetes & Endocrinology ◽

10.1016/s2213-8587(15)00289-2 ◽

2015 ◽

Vol 3 (12) ◽

pp. 993-1003 ◽

Cited By ~ 13

Author(s):

Murray Epstein

Keyword(s):

Chronic Kidney Disease ◽

Cardiovascular Risk ◽

Kidney Disease ◽

Receptor Antagonism ◽

Mineralocorticoid receptor antagonism in chronic kidney disease.

Kidney International Reports ◽

10.1016/j.ekir.2021.05.027 ◽

2021 ◽

Author(s):

Panagiotis I. Georgianos ◽

Rajiv Agarwal

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Receptor Antagonism ◽

Abstract P178: Mineralocorticoid Receptor Antagonism Improved the Metabolic Function in a Mouse Model With Chronic Kidney Disease and Obesity

Hypertension ◽

10.1161/hyp.74.suppl_1.p178 ◽

2019 ◽

Vol 74 (Suppl_1) ◽

Author(s):

Roberto Palacios Ramirez ◽

Benjamin Bonnard ◽

Frederic Jaisser

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Mouse Model ◽

Metabolic Function ◽

Receptor Antagonism ◽

Mineralocorticoid Receptor Antagonism Ameliorates Left Ventricular Diastolic Dysfunction and Myocardial Fibrosis in Mildly Symptomatic Patients With Idiopathic Dilated Cardiomyopathy

Circulation ◽

10.1161/circulationaha.105.571653 ◽

2005 ◽

Vol 112 (19) ◽

pp. 2940-2945 ◽

Cited By ~ 163

Author(s):

Hideo Izawa ◽

Toyoaki Murohara ◽

Kohzo Nagata ◽

Satoshi Isobe ◽

Hiroyuki Asano ◽

...

Keyword(s):

Dilated Cardiomyopathy ◽

Diastolic Dysfunction ◽

Myocardial Fibrosis ◽

Left Ventricular Diastolic Dysfunction ◽

Left Ventricular ◽

Idiopathic Dilated Cardiomyopathy ◽

Receptor Antagonism ◽

Ventricular Diastolic Dysfunction ◽

Mineralocorticoid Receptor Antagonism Treats Obesity-Associated Cardiac Diastolic Dysfunction

Hypertension ◽

10.1161/hypertensionaha.114.04912 ◽

2015 ◽

Vol 65 (5) ◽

pp. 1082-1088 ◽

Cited By ~ 58

Author(s):

Shawn B. Bender ◽

Vincent G. DeMarco ◽

Jaume Padilla ◽

Nathan T. Jenkins ◽

Javad Habibi ◽

...

Keyword(s):

Diastolic Dysfunction ◽

Receptor Antagonism ◽

Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study

Diabetes Therapy ◽

10.1007/s13300-021-01118-7 ◽

2021 ◽

Author(s):

Johannes J. Kovarik ◽

Christopher C. Kaltenecker ◽

Oliver Domenig ◽

Marlies Antlanger ◽

Marko Poglitsch ◽

...

Keyword(s):

Kidney Disease ◽

Exploratory Study ◽

Diabetic Kidney Disease ◽

Ace Inhibition ◽

Receptor Antagonism ◽

Diabetic Kidney ◽

Faculty Opinions recommendation of Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1165248.628191 ◽

2009 ◽

Author(s):

David Pollock

Keyword(s):

Blood Pressure ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Arterial Stiffness ◽

Receptor Antagonism ◽

Endothelin A Receptor ◽

Endothelin A ◽

Pressure Independent

Faculty Opinions recommendation of Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725989934.793514779 ◽

2016 ◽

Author(s):

Luis Ruilope ◽

Enrique Morales

Keyword(s):

Renal Disease ◽

Receptor Antagonism ◽

Faculty Opinions recommendation of Efficacy and safety of mineralocorticoid receptor antagonists in patients with heart failure and chronic kidney disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737121012.793571782 ◽

2020 ◽

Author(s):

Luis Ruilope ◽

Enrique Morales

Keyword(s):

Heart Failure ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Efficacy And Safety ◽

Mineralocorticoid Receptor Antagonists ◽

Receptor Antagonists ◽

Patients With Heart Failure